Key facts
- It has raised $10.5M; the latest was Later Stage VC in Jul 2024.
- Notable investors include Fundación Chile, AceleraLatam, ChileGlobal Ventures, Fen Ventures, Sunna Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Spora
- ·The full record, as it builds
Funding rounds
No funding rounds for Spora are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Spora
Operator of a biotechnological firm intended to provide bio-textile products to solve issues impacting climate change, animal abuse, and humanitarian issues around the world. The company's product is a mushroom-mycelium-based leather alternative that acts as a sustainable replacement for animal and synthetic leather, enabling clients to gain access to a climate and animal-friendly substitute.
- Sector
- Materials and Resources
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 59
- Website
- spora.co.uk/
- Ownership
- Privately Held (backing)
Spora doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Spora shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Spora in its N-PORT filings yet. We sweep new filings monthly.